Beauty Farm Medical and Health Industry Inc. provided group earnings guidance for the year ended December 31, 2023. For the year, the Group is expected to record the revenue of not less than RMB 2.12 billion, representing an increase of not less than 30% as compared to the corresponding period in 2022; a net profit of not less than RMB 221 million, representing an increase of not less than 100% as compared to the corresponding period in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.14 HKD | 0.00% | -3.20% | +36.64% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+36.64% | 461M | |
-23.55% | 519M | |
-19.70% | 451M | |
-5.60% | 266M | |
-22.20% | 95.88M | |
-1.64% | 83.41M | |
-3.66% | 80.67M | |
-20.69% | 61.01M | |
-3.85% | 59.43M | |
-33.33% | 58.45M |
- Stock Market
- Equities
- 2373 Stock
- News Beauty Farm Medical and Health Industry Inc.
- Beauty Farm Medical and Health Industry Inc. Provides Group Earnings Guidance for the Year Ended December 31, 2023